Publication:
Evaluation of peripheral and autonomic neuropathy among patients with newly diagnosed impaired glucose tolerance

Simple item page
dc.contributor.authorİŞAK, BARIŞ
dc.contributor.authorsIsak, Baris; Oflazoglu, Buket; Tanridag, Tulin; Yitmen, Irem; Us, Onder
dc.date.accessioned2022-03-12T17:33:37Z
dc.date.available2022-03-12T17:33:37Z
dc.date.issued2008
dc.description.abstractBackground We have aimed to investigate the presence of peripheral and autonomic neuropathy in individuals who had been diagnosed with impaired glucose tolerance (IGT) on the basis of an oral glucose tolerance test, by comparing with age-matched healthy subjects with an oral glucose tolerance test (OGTT) in normoglycernic ranges. Material and methods Conventional nerve conduction studies, heart rate variation variability, heart rate response to deep breathing, heart rate response blood pressure response to standing up quickly, hand to valsalva maneuvre, grip test and sympathetic skin response tests were used to evaluate the IGT and the control subjects. Results No obvious statistical difference indicating peripheral neuropathy and/or cardiac autonomic neuropathy was detected between patient group and controls. Amplitudes of sympathetic skin response of two limbs (right upper and lower extremities) were lower in the IGT patient group when compared to healthy controls (p < 0.05) indicating the presence of sudomotor autonomic neuropathy. Conclusion Complaints and neurological examinations of patients with IGT were thought to be consistent with small-fiber neuropathy in the early phase of glucose intolerance. Not detecting any neuropathic findings in conventional electroneurography should be attributed to insufficient time allowed for settling down of large-fiber neuropathy. Obtaining no response in some of the patients in addition to general decrease in the amplitudes of sympathetic skin responses indicates that sudomotor fibers tend to be affected earlier in autonomic neuropathy in the group with IGT when compared with healthy controls. Newly diagnosed IGT patients take receive priority in primary protection since the time for settling down of cardiac autonomic neuropathy was short. Copyright (c) 2008 John Wiley & Sons, Ltd.
dc.identifier.doi10.1002/dmrr.859
dc.identifier.eissn1520-7560
dc.identifier.issn1520-7552
dc.identifier.pubmed18636432
dc.identifier.urihttps://hdl.handle.net/11424/228881
dc.identifier.wosWOS:000260371700007
dc.language.isoeng
dc.publisherWILEY
dc.relation.ispartofDIABETES-METABOLISM RESEARCH AND REVIEWS
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectimpaired glucose tolerance
dc.subjectautonomic neuropathy
dc.subjectperipheral neuropathy
dc.subjectSYMPATHETIC SKIN-RESPONSE
dc.subjectSYMPTOM PROFILE
dc.subjectPREVALENCE
dc.subjectDISEASE
dc.subjectRISK
dc.titleEvaluation of peripheral and autonomic neuropathy among patients with newly diagnosed impaired glucose tolerance
dc.typearticle
dspace.entity.typePublication
local.avesis.id87887103-77ce-4913-ad86-087711d6ea24
local.import.packageSS17
local.indexed.atWOS
local.indexed.atSCOPUS
local.indexed.atPUBMED
local.journal.numberofpages7
oaire.citation.endPage569
oaire.citation.issue7
oaire.citation.startPage563
oaire.citation.titleDIABETES-METABOLISM RESEARCH AND REVIEWS
oaire.citation.volume24
relation.isAuthorOfPublication3978eebd-304b-4af3-930c-2db9759c860d
relation.isAuthorOfPublication.latestForDiscovery3978eebd-304b-4af3-930c-2db9759c860d

Files

Collections

Research Outputs